Fisher, B. A. C., et al. “Cardiovascular complications induced by cannabis smoking: a case report and review of the literature.” Emergency medicine journal 22.9 (2005): 679-680.
Kosier, D., et al. Paroxysmal Atrial Fibrillation Following Marijuana Intoxication: A Two-case Report of Possible Association. International Journal of Cardiology (2001) 78: 183-84
Singh, G. Atrial Fibrillation Associated with Marijuana Use. Pediatric Cardiology (2000) 21: 248
Aronow, W., et al. Effect of Marihuana and Placebo-marihuana Smoking on Angina Pectoris. New England Journal of Medicine (1974) 291: 65-67
Mittleman, M., et al. Triggering Myocardial Infarction by Marijuana. Circulation. (2001) 103:2805
Fisher, B. A. C., et al.
Caldicott, D., et al. Keep off the grass: marijuana use and acute cardiovascular events. European Journal of Emergency Medicine (2005) 12: 236-244
Mukamal, K. An Exploratory Prospective Study of Marijuana Use and Mortality Following Acute Myocardial Infarction. American Heart Journal (2008) 155: 465-470
Axiyan, Maihemuti, et al. “CardiovasculaR Disease among us adult marijuana users: National Health and Nutrition Examination Survey, 2011-2012.” Journal of the American College of Cardiology 65.10_S (2015).
Tashkin, Donald P., et al. “Respiratory Symptoms and Lung Function in Habitual Heavy Smokers of Marijuana Alone, Smokers of Marijuana and Tobacco, Smokers of Tobacco Alone, and Nonsmokers 1–3.” American Review of Respiratory Disease 135.1 (1987): 209-216.
Bloom, John W., et al. “Respiratory effects of non-tobacco cigarettes.” BMJ 295.6612 (1987): 1516-1518.
Tashkin, Donald P., et al.
Bloom, John W., et al.
Aldington, Sarah, et al. “Effects of cannabis on pulmonary structure, function and symptoms.” Thorax 62.12 (2007): 1058-1063.
Taylor, D. Robin, et al. “The respiratory effects of cannabis dependence in young adults.” Addiction 95.11 (2000): 1669-1677
Moore, Brent A., et al. “Respiratory effects of marijuana and tobacco use in a US sample.” Journal of General Internal Medicine 20.1 (2005): 33-37.
Tashkin, Donald P., Michael S. Simmons, and Chi-Hong Tseng. “Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis.” COPD: Journal of Chronic Obstructive Pulmonary Disease 9.4 (2012): 367-374.
Tashkin, Donald P., et al.
Aldington, Sarah, et al.
Hancox, Robert J., et al. “Effects of cannabis on lung function: a population-based cohort study.” European Respiratory Journal 35.1 (2010): 42-47.
Sidney, Stephen, et al. “Marijuana use and cancer incidence (California, United States).” Cancer Causes & Control 8.5 (1997): 722-728.
Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM,Roth MD. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 1997;156: 1606–13
Hashibe, Mia, et al. “Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study.” Cancer Epidemiology Biomarkers & Prevention 15.10 (2006): 1829-1834.
Tan, Wan C., et al. “Marijuana and chronic obstructive lung disease: a population-based study.” Canadian Medical Association Journal 180.8 (2009): 814-820.
Tashkin, Donald P. “Effects of marijuana smoking on the lung.” Annals of the American Thoracic Society 10.3 (2013): 239-247.
Tunbridge, R. J., et al. The influence of cannabis on driving. Crowthorne: Transport Research Laboratory, 2000
Smiley, Alison M., H. Moskowitz, and K. Zeidman. “Driving simulator studies of marijuana alone and in combination with alcohol.” Proceedings: American Association for Automotive Medicine Annual Conference. Vol. 25. Association for the Advancement of Automotive Medicine, 1981.
Bedard, M., et al. The impact of cannabis on driving. Canadian Journal of Public Health (2007) 98: 6-11
Drummer, O., et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accident Analysis and Prevention (2004) 36: 239-48
Grotenhermen, F., et al. Developing science-based per se limits for driving under the influence of cannabis. http://www.canormL.org/healthfacts/DUICreport2005.pdf (2005)
US Department of Transportation, National Highway Traffic Safety Administration. The Incidence and Role of Drugs in Fatally Injured Drivers: Final Report, October 1992
Drummer, O., et al.
The Incidence and Role of Drugs in Fatally Injured Drivers: Final Report, October 1992
Williams, A., et al. Drugs in Fatally Injured Young Male Drivers. Public Health Reports (1985) 100: 19-25
Bates, M., Role of cannabis in motor vehicle crashes. Epidemiological Reviews (1999) 21:222-232
Drummer, O., et al.
Grotenhermen, F., Pharmacokinetics and Pharmacodynamics of Cannbinoid. Clinical Pharmacokinetics (2003) 42: 327-60
Fried, P., et al. A Literature Review of the Consequences of Prenatal Marijuana Exposure: An Emerging Theme of a Deficiency in Aspects of Executive Function. Neurotoxicology and Teratology (2001) 23: 1-11
Hurd, Y., et al. Marijuana Impairs Growth in Mid-gestation Fetuses. Neurotoxicology and Teratology (2005): 221-29
Fried, P., et al
Marroun H., et al. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug and Alcohol Dependence (2011) April
Astley S., et al. Maternal marijuana use during lactation and infant development at one year. Neurotoxicology and Teratology (1990) 12:161-168
Tennes, K., et al. Marijuana: Prenatal and Postnatal Exposure in the Human. In T. M. Pinkert (ed.), Current Research on the Consequences of Maternal Drug Abuse (Rockville, MD: National Institute on Drug Abuse, 1985) pg 48–60
Dreher et al. 1994. Prenatal marijuana exposure and neonatal outcomes in Jamaica: An ethonographic study. Pediatrics 93: 254-260.
Huizink, Anja C., and Eduard JH Mulder. “Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring.” Neuroscience & Biobehavioral Reviews 30.1 (2006): 24-41.
Lee, TT-Y., and B. B. Gorzalka. “Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic–pituitary–adrenal axis activity across developmental periods.” Neuroscience 204 (2012): 17-30.
Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry. 2013;4:129
Díaz-Alonso, Javier, Manuel Guzmán, and Ismael Galve-Roperh. “Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development.” Philosophical Transactions of the Royal Society B: Biological Sciences 367.1607 (2012): 3229-3241.
Malone, Daniel T., Matthew N. Hill, and Tiziana Rubino. “Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.” British journal of pharmacology 160.3 (2010): 511-522.
Rubino, Tiziana, et al. “Chronic Δ9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.” Neuropsychopharmacology 33.11 (2008): 2760-2771.
Rubino, T., and D. Parolaro. “Long lasting consequences of cannabis exposure in adolescence.” Molecular and cellular endocrinology 286.1 (2008): S108-S113.
Trezza, Viviana, and Louk JMJ Vanderschuren. “Bidirectional cannabinoid modulation of social behavior in adolescent rats.” Psychopharmacology 197.2 (2008): 217-227.
Renard, Justine, et al. “Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.” Frontiers in neuroscience 8 (2014).
Meier, M.H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R.S., et al., 2012. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl Acad. Sci. USA 109 (40), E2657E2664.
Sugranyes, Gisela, et al. “Cannabis use and age of diagnosis of schizophrenia.” European psychiatry 24.5 (2009): 282-286.
Arseneault, Louise, et al. “Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.” Bmj 325.7374 (2002): 1212-1213.
Stefanis, N. C., et al. “Early adolescent cannabis exposure and positive and negative dimensions of psychosis.” Addiction 99.10 (2004): 1333-1341.